Adenocarcinoma gastric+1
Not yet recruitingDurvalumab with chemotherapy drug combination versus surveillance in patients with low‑risk localized stomach or gastroesophageal junction cancer
Durvalumab with chemotherapy drug combination versus surveillance in patients with low‑risk localized stomach or gastroesophageal junction cancer
- Disease:Adenocarcinoma gastricGastric cancer
- Substances:Calcium FolinateDocetaxel+3
France- Participants:18–64 years · 65+ years
- Substances:Calcium Folinate
- Sponsor:Centre Leon Berard





